Table 5.
Correlations between Srx, PROX1 and Nrf2 levels in the studied gastric cancer patients and their outcome
| Parameter | Dead | Alive | p-value | OR | 95% CI |
|---|---|---|---|---|---|
| Srx | < 0.001 | 270 | 22.8–3189.4 | ||
| Low | 1 (3.6) | 20 (90.9) | |||
| High | 27 (96.4) | 2 (9.1) | |||
| PROX1 | < 0.001 | 130 | 16.82–1004.6 | ||
| Low | 26 (92.9) | 2 (9.1) | |||
| High | 2 (7.1) | 20 (90.9) | |||
| Nrf2 | < 0.001 | 37.5 | 7.46–188.53 | ||
| Low | 3 (10.7) | 18 (81.8) | |||
| High | 25 (89.3) | 4 (18.2) |
OR – odds ratio, CI – confidence interval